Rheumatology

Psoriatic Arthritis

Expert Roundtables Podcast: Cross-Comparison of Targeted Therapies for Psoriatic Arthritis

expert roundtables by M. Elaine Husni, MD, MPH; Philip J. Mease, MD, MACR

Overview

Currently, a wealth of targeted therapies is available for the treatment of psoriatic arthritis, including oral, subcutaneous, and intravenous options. In today’s podcast, our experts explain how they discuss these therapies with patients to support shared decision making.

References

Coyle C, Watson L, Whately-Smith C, et al. How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients. Rheumatology (Oxford). 2025;64(1):242-251. doi:10.1093/rheumatology/kead679

Tomo ATJ, Ratan P, Gonçalves LS, et al. Cycling versus swapping strategies for treatment of psoriatic arthritis after primary tumour necrosis factor inhibitors failure: a systematic review and meta-analysis. Rheumatology (Oxford). 2026;65(6):keag281. doi:10.1093/rheumatology/keag281

Watad A, Elizur Y, Hen O, et al. Impact of biologic class and treatment line on psoriatic arthritis risk in psoriasis: a population-based cohort study. RMD Open. 2026;12(2):e006687. doi:10.1136/rmdopen-2025-006687

Watson L, Coyle C, Whately-Smith C, et al. An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis. Rheumatology (Oxford). 2024;63(12):3449-3456. doi:10.1093/rheumatology/kead621

Profile

M. Elaine Husni, MD, MPH

Vice Chair and Director
Arthritis & Musculoskeletal Center
Scholtz Family Chair of Translational Functional Medicine Research
Cleveland Clinic
Cleveland, OH

Profile

Philip J. Mease, MD, MACR

Director of Rheumatology Research
Providence Swedish Medical Center
Clinical Professor of Medicine
University of Washington School of Medicine
Seattle, WA